Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Farrell, M. A.
Right arrow Articles by Ebers, G. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Farrell, M. A.
Right arrow Articles by Ebers, G. C.
NEUROLOGY 1985;35:212
© 1985 American Academy of Neurology

Oligoclonal bands in multiple sclerosis

Clinical-pathologic correlation

M. A. Farrell, J. C. E. Kaufmann, J. J. Gilbert, J. H. Noseworthy, H. A. Armstrong and G. C. Ebers

Department of Clinical Neurological Sciences and the Department of Pathology, The University of Western Ontario, London, Ontario, Canada.

Although oligoclonal banding is a characteristic feature of MS spinal fluid, some patients do not show this abnormality. Four of 18 consecutive patients with autopsy-proven MS had no oligoclonal bands (OB) in CSF during life or at postmortem. Patients with OB had numerous plasma cells in meninges and plaques (confirmed in sections stained for cytoplasmic immunoglobulin). The four patients without bands had few or no identifiable plasma cells. Therefore, lack of OB correlates with both inactivity of plaques and absence of plasma cells in plaques or meninges. This is another form of heterogeneity in MS.

Address correspondence and reprint requests to Dr. Ebers, Department of Clinical Neurological Sciences, University Hospital, P.O. Box 5339, London. Ontario, Canada N6A 5A5.

Supported by grants from the Multiple Sclerosis Society of Canada and the P. S. I. Foundation.

Accepted for publication June 6, 1984.




This article has been cited by other articles:


Home page
NeurologyHome page
G. Davies, G. Keir, E. J. Thompson, and G. Giovannoni
The clinical significance of an intrathecal monoclonal immunoglobulin band: A follow-up study
Neurology, April 8, 2003; 60(7): 1163 - 1166.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S. Kikuchi, T. Fukazawa, M. Niino, I. Yabe, R. Miyagishi, T. Hamada, S. A. Hashimoto, and K. Tashiro
HLA-related subpopulations of MS in Japanese with and without oligoclonal IgG bands
Neurology, February 25, 2003; 60(4): 647 - 651.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
J. R. Avasarala, A. H. Cross, and J. L. Trotter
Oligoclonal Band Number as a Marker for Prognosis in Multiple Sclerosis
Arch Neurol, December 1, 2001; 58(12): 2044 - 2045.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1985 by AAN Enterprises, Inc.